These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways. Han K; Li C; Zhang X; Shang L Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112 [TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224 [TBL] [Abstract][Full Text] [Related]
5. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development. Zhang N; Chen X Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159 [TBL] [Abstract][Full Text] [Related]
6. LncRNA ZFAS1 regulates ATIC transcription and promotes the proliferation and migration of hepatocellular carcinoma through the PI3K/AKT signaling pathway. Luo B; Zhuang L; Huang J; Shi L; Zhang L; Zhu M; Lu Y; Zhu Q; Sun D; Wang H; Fang H J Cancer Res Clin Oncol; 2024 Jul; 150(7):351. PubMed ID: 39001904 [TBL] [Abstract][Full Text] [Related]
7. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target. Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213 [No Abstract] [Full Text] [Related]
8. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation. Chen CL; Tseng YW; Wu JC; Chen GY; Lin KC; Hwang SM; Hu YC Biomaterials; 2015 Mar; 44():71-81. PubMed ID: 25617127 [TBL] [Abstract][Full Text] [Related]
9. Down-regulated PLAC8 promotes hepatocellular carcinoma cell proliferation by enhancing PI3K/Akt/GSK3β/Wnt/β-catenin signaling. Zou L; Chai J; Gao Y; Guan J; Liu Q; Du JJ Biomed Pharmacother; 2016 Dec; 84():139-146. PubMed ID: 27643556 [TBL] [Abstract][Full Text] [Related]
10. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway. Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274 [TBL] [Abstract][Full Text] [Related]
11. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway. Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway. Liu Z; Mo H; Sun L; Wang L; Chen T; Yao B; Liu R; Niu Y; Tu K; Xu Q; Yang N Cancer Sci; 2020 Nov; 111(11):4118-4128. PubMed ID: 32860321 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling. Tian X; Wu Y; Yang Y; Wang J; Niu M; Gao S; Qin T; Bao D Mol Oncol; 2020 Feb; 14(2):462-483. PubMed ID: 31785055 [TBL] [Abstract][Full Text] [Related]
14. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism. Ellis BC; Graham LD; Molloy PL Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis. Lin C; Xiang Y; Sheng J; Liu S; Cui M; Zhang X J Physiol Biochem; 2020 Aug; 76(3):469-481. PubMed ID: 32621257 [TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA Myd88 promotes growth and metastasis in hepatocellular carcinoma via regulating Myd88 expression through H3K27 modification. Xu X; Yin Y; Tang J; Xie Y; Han Z; Zhang X; Liu Q; Qin X; Huang X; Sun B Cell Death Dis; 2017 Oct; 8(10):e3124. PubMed ID: 29022910 [TBL] [Abstract][Full Text] [Related]
17. LINC01133 aggravates the progression of hepatocellular carcinoma by activating the PI3K/AKT pathway. Zheng YF; Zhang XY; Bu YZ J Cell Biochem; 2019 Mar; 120(3):4172-4179. PubMed ID: 30548306 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of LncRNA NR027113 inhibits cell proliferation and metastasis via PTEN/PI3K/AKT signaling pathway in hepatocellular carcinoma. Chen Z; Zhou ZY; He CC; Zhang JL; Wang J; Xiao ZY Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7222-7232. PubMed ID: 30468465 [TBL] [Abstract][Full Text] [Related]
19. EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway. Lei T; Zhu X; Zhu K; Jia F; Li S Cancer Biol Ther; 2019; 20(7):1007-1016. PubMed ID: 30929558 [TBL] [Abstract][Full Text] [Related]
20. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway. Wu L; Zheng J; Chen P; Liu Q; Yuan Y Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]